COMPARATIVE STUDY OF THE SUBSTANTIA NIGRA ECHOGENICITY AND 123I-IOFLUPANE SPECT IN PATIENTS WITH REM SLEEP BEHAVIOR DISORDER

被引：0
|
作者：
Maskova, J. [1 ,2 ,3 ]
Skoloudik, D. [1 ,2 ,3 ,4 ]
Dusek, P. [1 ,2 ,3 ,5 ]
Sonka, K. [1 ,2 ,3 ]
Losada, V. Ibarburu Lorenzo Y. [1 ,2 ,3 ]
Kemlink, D. [1 ,2 ,3 ]
Dusek, P. [1 ,2 ,3 ,5 ]
Kubinyi, J. [6 ]
Trnka, J. [6 ]
Krupicka, R. [7 ]
Ruzicka, E. [1 ,2 ,3 ]
机构：
[1] Charles Univ Prague, Dept Neurol, Prague, Czech Republic
[2] Charles Univ Prague, Ctr Clin Neurosci, Fac Med 1, Prague, Czech Republic
[3] Charles Univ Prague, Gen Teaching Hosp Prague, Prague, Czech Republic
[4] Palacky Univ Olomouc, Fac Hlth Sci, Dept Nursing, Olomouc, Czech Republic
[5] Charles Univ Prague, Fac Med 1, Dept Radiol, Prague, Czech Republic
[6] Charles Univ Prague, Fac Med 1, Dept Nucl Med, Prague, Czech Republic
[7] Czech Tech Univ, Dept Biomed Informat, Fac Biomed Engn, Prague, Czech Republic
来源：
SLEEP MEDICINE | 2017年 / 40卷
关键词：
D O I：
10.1016/j.sleep.2017.11.619
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E212 / E212
页数：1
相关论文
共 50 条
  • [31] Substantia nigra rest-state fMRI correlation differences between REM sleep behavior disorder and early PD patients
    Ellmore, T.
    Hendley, K. L.
    Aalbers, B. M.
    Furr-Stimming, E. E.
    Hood, A. J.
    Castriotta, R.
    Schiess, M. C.
    MOVEMENT DISORDERS, 2011, 26 : S124 - S125
  • [32] Comparison study of olfactory function and substantia nigra hyperechogenicity in idiopathic REM sleep behavior disorder, Parkinson’s disease and normal control
    Hee Young Shin
    Eun Youn Joo
    Seong Tae Kim
    Hun-Jong Dhong
    Jin Whan Cho
    Neurological Sciences, 2013, 34 : 935 - 940
  • [33] Comparison study of olfactory function and substantia nigra hyperechogenicity in idiopathic REM sleep behavior disorder, Parkinson's disease and normal control
    Shin, Hee Young
    Joo, Eun Youn
    Kim, Seong Tae
    Dhong, Hun-Jong
    Cho, Jin Whan
    NEUROLOGICAL SCIENCES, 2013, 34 (06) : 935 - 940
  • [34] Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder
    Miyamoto, T.
    Miyamoto, M.
    Inoue, Y.
    Usui, Y.
    Suzuki, K.
    Hirata, K.
    NEUROLOGY, 2006, 67 (12) : 2236 - 2238
  • [35] Diagnostic performance of the visual reading of 123I-ioflupane DaT SPECT images when assessed with or without quantification in patients with movement disorders or dementia
    Booij, Jan
    Pryma, Daniel
    Dubroff, Jacob
    Yu, Jian
    Agarwal, Rajan
    Lakhani, Paras
    Kuo, Phillip
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [36] Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism:: 2-year follow-up of an open-label study
    Tolosa, Eduardo
    Vander Borght, Thierry
    Moreno, Emilio
    MOVEMENT DISORDERS, 2007, 22 (16) : 2346 - 2351
  • [37] [I-123]IPT-binding to the presynaptic dopamine transporter in patients with idiopathic REM sleep behavior disorder
    Linke, R
    Eisensehr, I
    Noachtar, S
    Schwarz, J
    Pöpperl, G
    Hahn, K
    Tatsch, K
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 973 - 973
  • [38] Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder
    Frosini, Daniela
    Cosottini, Mirco
    Donatelli, Graziella
    Costagli, Mauro
    Biagi, Laura
    Pacchetti, Claudio
    Terzahi, Michele
    Cortelli, Pietro
    Arnaldi, Dario
    Bonanni, Enrica
    Tosetti, Michela
    Bonuccelli, Ubaldo
    Ceravolo, Roberto
    PARKINSONISM & RELATED DISORDERS, 2017, 43 : 105 - 109
  • [39] DETERMINANTS OF DECREASED CARDIAC UPTAKE IN 123I-MIBG SCINTIGRAPHY IN PATIENTS WITH IDIOPATHIC REM SLEEP BEHAVIOR DISORDER
    Tachibana, N.
    Taniguchi, K-I.
    Ishii, T.
    Hamano, T.
    SLEEP MEDICINE, 2017, 40 : E323 - E323
  • [40] Comparative Study between the Diagnostic Effectiveness of Brain SPECT with [123I]Ioflupane and [123I]MIBG Scintigraphy in Multiple System Atrophy
    Villena-Salinas, Javier
    Ortega-Lozano, Simeon Jose
    Amrani-Raissouni, Tomader
    Aguera-Morales, Eduardo
    Caballero-Villarraso, Javier
    BIOMEDICINES, 2024, 12 (01)
12345